Canacik and colleagues identified AnxA1 as a biomarker for the severity of COVID-19, as the levels of the protein in the serum of patients with the severe disease were decreased compared to those of healthy volunteers, or even patients with mild disease [89]. The gene discussed is ANXA1; the disease is COVID-19.